Ecolab
Razor/razorblade recurring-service: places dispensing equipment and digital sensors at customer sites, then sells consumable chemicals, monitoring, and a large (~48,000-associate) sales-and-service field force under multi-year embedded contracts. Blend of consumables (high-recurring) + equipment + software/data, with a newer high-tech water/cooling hardware leg (CoolIT).
Earnings, margins, COGS & capex
A high-quality, slow-and-steady compounder: low-single-digit reported revenue growth and low-single-digit organic growth converted into consistent low-double-digit adjusted EPS growth (12-15%/yr) via pricing power and margin expansion. FY2025 revenue $16.08B, net income ~$2.08B (~13% net margin), record FCF ~$1.9B, reported diluted EPS $7.28 / adjusted $7.53. Balance sheet investment-grade but leverage stepped up (~1.6x standalone to ~3x pro forma) to fund the ~$4.75B CoolIT AI-cooling deal. The growth engine is shifting from mature core hygiene toward high-tech/data-center water + liquid cooling and Life Sciences.
Income statement — where each revenue dollar goes
% of revenueOf every $1 of revenue, ~56¢ is cost of goods and ~28¢ operating expense, leaving ~17¢ of operating profit (~13¢ net).
Revenue trend
Margins
up YoY on pricing + lower delivered product cost
up modestly YoY
up ~100bps YoY; multi-year expansion toward a ~20% ambition (FY2026 guide: +100-150bps)
stable (net income ~$2.08B, -2% YoY reported)
record FCF ~$1.9B; stable/improving
COGS structure
Delivered product cost is dominated by chemical raw materials (caustic soda/chlor-alkali, surfactants, polymers, resins) plus packaging, freight, and the field-service labor embedded in the service model. Raw-material moderation plus value pricing drove the FY2025 gross-margin gain; Ecolab prices to recover input inflation with a lag. The CoolIT hardware leg adds an equipment/BOM cost mix not previously prominent.
Capex
~$1.0B in FY2025 (~6% of sales), for dispensing/monitoring equipment placed at customer sites, plants, and digital/sensor infrastructure. Capex intensity is moderate for a specialty-chemical company because much value is service/consumables, not heavy plant.
Latest earnings
Revenue a slight beat of consensus; adjusted EPS in line to a slight beat; management reaffirmed the FY2026 12-15% adjusted-EPS framework
FY2026 adjusted diluted EPS $8.43-$8.63 (+12-15% off $7.53); reported sales growth guided ~7-9% organically-driven, lifting toward ~9-11% as CoolIT/Ovivo M&A adds to the base; adjusted operating margin +100-150bps
- FY2025 adjusted diluted EPS
- $7.53 (+~14% YoY)
- FY2025 reported diluted EPS
- $7.28 (-1% YoY; FX + special charges)
- FY2025 net income
- ~$2.08B (-2% YoY)
- FY2025 free cash flow
- ~$1.9B (record)
- Net leverage
- ~1.6x standalone; ~3x pro forma post-CoolIT, guided back to ~2x in ~2 yrs
Growth drivers
- High-tech / data-center water & liquid cooling — cooling and process water for hyperscaler AI buildout, now anchored by the CoolIT acquisition (~$550M forward sales, growth >100% YTD); Ecolab targets a ~$4B Global High Tech business by 2030
- Pricing power — consistent value-based price increases across the installed base (3pts of Q1 2026's 4% organic came from pricing)
- Global Life Sciences — elevated to a standalone reporting segment (pharma/biotech contamination control, higher-growth/higher-margin)
- Digital (ECOLAB3D / 3D TRASAR) — sensor + software layer that raises switching costs and adds recurring software-like revenue
- Margin expansion — mix shift, digital, and productivity driving adjusted operating margin toward the ~20% ambition
- Bolt-on M&A (CoolIT, Ovivo Electronics ultrapure water) funded by strong FCF + debt
Reported financials — SEC EDGAR
Audited GAAP figures pulled from SEC filings · latest filing 2026-02-23. The audited primary-source spine — not financial advice.
Revenue — annual (GAAP)
Margins & balance sheet — FY’25
Bull & bear
A rare industrial compounder: mission-critical, embedded service revenue with pricing power, a widening digital moat, and a now-owned secular tailwind in AI-data-center cooling (CoolIT) — capable of sustaining 12-15% EPS growth for years, which historically supports a premium multiple.
- Consumable + service model means revenue is sticky and recurring; customers rarely rip out an embedded Ecolab program over price alone
- Demonstrated ability to convert low-single-digit organic sales growth into ~12-15% adjusted EPS growth via pricing and margin expansion — a durable algorithm
- CoolIT converts the data-center thesis from narrative to owned revenue: >100% YTD growth, ~$550M forward sales, and a stated ~$4B-by-2030 Global High Tech ambition tied to the AI capex cycle
- Adjusted operating margin still expanding toward ~20%, with digital and mix as multi-year levers (FY2026 guide +100-150bps)
- Fortress FCF (~$1.9B) plus a Dividend-Aristocrat record funds dividend growth, buybacks, and bolt-on M&A even alongside the CoolIT debt
- Water scarcity and ESG regulation structurally increase willingness to pay for Ecolab's efficiency services
You are paying ~33-39x earnings for a business growing core organic revenue at ~2-3% — the premium rests on the pricing-plus-margin algorithm continuing flawlessly, and now on a debt-funded (~3x pro forma) bet on AI cooling in a field of deep-pocketed rivals; a well-capitalized PE competitor plus raw-material and cyclical risk make a stumble plausible.
- Core organic growth is low-single-digit; strip pricing and the volume story is mature and slow
- Valuation (~33x forward, ~39x trailing reported) prices in years of continued double-digit EPS growth — any miss re-rates the stock hard
- Solenis/Diversey (Platinum Equity-backed, ~$8B) is discounting aggressively in Ecolab's two biggest arenas, pressuring price/mix
- CoolIT lifts net leverage to ~3x pro forma and drops Ecolab into liquid cooling against Vertiv/Boyd and hyperscaler in-house designs — integration and competitive-position risk in a business new to Ecolab
- Margins hinge on delivered product cost; a raw-material or energy inflation spike ahead of pricing compresses the model
- Heavy international mix means FX can erase reported growth even in good organic years
- Low ~1.0-1.1% yield offers little valuation cushion in a de-rating
What it is worth
Premium-quality-compounder framing: forward P/E on adjusted EPS + EV/EBITDA cross-check, anchored to the durability of the 12-15% adjusted-EPS-growth algorithm and now to CoolIT's AI-cooling optionality.
~$200-220
a growth, margin, or CoolIT-integration stumble (PE price competition, input inflation, FX, softer volumes, cooling competition) re-rates the multiple toward ~25-27x, and the thin yield + higher leverage provide little support.
~$280-300
~12-15% adjusted EPS growth on ~$8.5 EPS at a roughly maintained ~33-35x multiple; total return tracks EPS growth plus a modest dividend.
~$340+
algorithm intact, CoolIT/data-center cooling and Life Sciences accelerate, adjusted margin pushes toward 20%, ~$9+ adjusted EPS holds a ~37-40x multiple.
At ~$282 and ~$79.5B market cap, ECL trades at ~33x FY2026 adjusted EPS guidance (~$8.53 midpoint), ~37x trailing adjusted ($7.53), and ~39x trailing reported EPS ($7.28) — a rich multiple justified only if the pricing + margin-expansion algorithm keeps compounding and CoolIT scales. EV/EBITDA in the mid-to-high-20s (elevated by the ~$4.75B CoolIT debt); ~1.0-1.1% dividend yield. The premium is the story: you underwrite consistency plus AI-cooling optionality, not cheapness.
SWOT
Strengths
- Global #1 in water treatment chemicals and in institutional cleaning/sanitizing — scale no single competitor matches across both
- Embedded on-site service model with ~48,000 associates creates deep switching costs and daily customer contact
- Recurring, consumable-heavy revenue with pricing power → durable ~12-15% adjusted EPS growth track record
- Strong, consistent FCF (record ~$1.9B in FY2025) and an investment-grade balance sheet
- Digital differentiation (3D TRASAR sensors, ECOLAB3D) turning a chemicals business into a data business
- CoolIT gives Ecolab a real, fast-growing foothold in AI-data-center liquid cooling rather than only a water-adjacent narrative
Weaknesses
- Low reported and organic top-line growth in the core (~2-3% in FY2025) — heavily reliant on pricing and mix rather than volume in mature markets
- Premium valuation (~33x forward, ~39x trailing reported EPS) leaves little room for execution error
- Exposure to chemical raw-material cost swings; margin depends on pricing staying ahead of input inflation
- Large FX translation drag given majority-international operations
- Leverage stepped up to ~3x pro forma to fund CoolIT, adding integration and deleveraging execution risk to a formerly fortress balance sheet
- Low dividend yield (~1.0-1.1%) — total return depends on continued multiple + earnings compounding
Opportunities
- AI/data-center cooling and process water — now a directly-owned platform via CoolIT, targeting ~$4B Global High Tech revenue by 2030
- Life Sciences scale-up as a standalone segment (pharma/biotech contamination control)
- Water scarcity + tightening ESG/discharge regulation increases the value of water-efficiency services
- Continued adjusted operating-margin expansion toward ~20%
- Bolt-on M&A in fragmented water, hygiene, and high-tech-water niches (Ovivo Electronics ultrapure water added)
Threats
- Private-equity-backed Solenis/Diversey (~$8B combined revenue) competing aggressively on price in industrial water and institutional hygiene
- In liquid cooling, well-funded incumbents (Vertiv, Boyd, and OEM/hyperscaler in-house designs) contest the CoolIT thesis
- End-market cyclicality — industrial, hospitality, food & beverage volumes soften in a downturn
- Raw-material or energy inflation outrunning price increases
- Regulatory/PFAS and chemical-handling liability across a broad product portfolio
- Multiple compression if growth or margin cadence slips even modestly
Moats, dependencies & bottlenecks
Moats
On-site technicians, dispensing equipment, and integrated monitoring make Ecolab part of the customer's operations; ripping it out risks food-safety, uptime, and compliance failures.
Largest combined water + hygiene field force and route density; unmatched ability to serve multi-site national/global accounts (hotels, restaurants, hospitals, plants).
Installed sensor base generates proprietary operating data that improves service and deepens lock-in; hardest for smaller rivals to replicate.
In food safety, healthcare infection prevention, and life sciences, Ecolab's compliance track record is a purchase criterion, not a commodity input.
Equipment placement seeds annuity chemical + service revenue with pricing power; CoolIT extends the placed-equipment logic into data-center cooling.
Dependencies
surfactants, polymers, resins) Delivered product cost drives gross margin; Ecolab prices to recover inflation with a lag. Suppliers include Dow, Olin, BASF, Nouryon.
Macro/translation Translation swings routinely move reported growth by several points vs. fixed-currency.
hospitality, food & beverage, healthcare) Volume growth tracks customer activity; downturns hit hospitality/industrial water usage.
The service moat is also a large labor cost base; wage inflation and hiring are structural dependencies.
Now a direct exposure via CoolIT liquid cooling; a slowdown in hyperscaler buildout would hit the highest-growth new leg and the ~$4B-by-2030 High Tech target.
Advantages
- Dual leadership across both water treatment and institutional hygiene — few competitors span both
- Recurring, consumable-heavy revenue with proven pricing power
- Digital/sensor layer converting chemicals into a data-and-service annuity
- Owned entry into AI-data-center liquid cooling (CoolIT), adjacent to existing high-tech water service
- Strong FCF conversion and investment-grade balance sheet enabling steady capital return + M&A
- Dividend Aristocrat with a multi-decade compounding record
Weaknesses
- Low reported and organic core revenue growth relative to a premium valuation
- Sensitivity to raw-material and energy cost cycles
- Large FX exposure
- Aggressive PE-backed price competition from Solenis/Diversey
- Elevated ~3x pro forma leverage and integration risk from the CoolIT deal
- Thin ~1.0-1.1% dividend yield offers little valuation support
Bottlenecks
- Mature core hygiene/water markets — organic volume growth is limited; the model leans on price and mix
- Pricing-vs-input-cost timing lag on gross margin
- FX translation repeatedly muting reported top-line despite healthier organic growth
- Scaling data-center cooling (CoolIT) and Life Sciences fast enough to move a $16B base meaningfully, while integrating a hardware business new to Ecolab
- Field-labor availability and cost to sustain the on-site service model
- Deleveraging from ~3x pro forma back toward ~2x while continuing capital return
Top signals & trends
Top signals
Management reaffirming the long-run algorithm signals confidence in pricing + margin cadence.
Margin, not core volume, is the primary EPS engine and it keeps grinding higher.
Underscores how much of the growth story is price/mix and margin rather than volume demand.
De-risks the data-center thesis into real revenue and a ~$4B-by-2030 High Tech target, at the cost of higher leverage.
Integration + deleveraging execution risk on a formerly ~1.6x balance sheet.
Direct pressure on price/mix in Ecolab's two largest arenas.
Trends
Water and heat are becoming binding constraints on hyperscaler buildout — a durable new demand pool Ecolab now serves directly via CoolIT.
Raises willingness to pay for measured water reduction and reuse.
Sensor/AI-driven monitoring deepens the moat and adds software-like revenue.
Broad chemical portfolio carries compliance and potential liability exposure.
Better-capitalized, price-aggressive consolidated competitor.
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
Base chemicals, surfactants, and polymer feedstocks.
Chlor-alkali / caustic soda — core water-treatment input.
Specialty chemical intermediates and surfactants (context).
Private; specialty/surfactant and polymer chemistries.
Large institutional cleaning, laundry, and warewashing accounts.
Food-safety, sanitation, and pest programs across many sites.
Growing demand for cooling/process water and liquid cooling as AI buildout scales (served via Global Water + CoolIT).
Infection prevention, sterilization, and Life Sciences contamination control.
Food & beverage processors and heavy industry Industrial water treatment, CIP, and process hygiene across manufacturing/mining/energy.
Water quality/analytics and treatment instrumentation (spun from Danaher, 2023); competes on the monitoring/instrumentation edge of water.
Water technology, pumps, and treatment systems/analytics; overlaps in industrial water infrastructure.
Private (Platinum Equity). ~$8B combined revenue after the 2023 Diversey merger; Ecolab's most direct head-to-head rival in both industrial water treatment and institutional hygiene, competing aggressively on price.
Data-center thermal management and liquid cooling; a leading rival to Ecolab's newly acquired CoolIT in AI-data-center cooling.
Japan/Asia industrial water treatment leader; regional strength and tailored chemistries (context only, not a buy/own call).
U.S. pest control leader; competes with Ecolab's Global Pest Elimination segment.
World's #1 pest control company; overlaps Ecolab's pest segment (a minor Ecolab segment).
Infection prevention / sterilization; overlaps healthcare and Life Sciences contamination control.
Global water/environmental services and treatment chemicals; large European competitor.